Development and Validation of a HPLC-PDA Method to Quantification of Ketobemidone in Rat Plasma and its' Application in Pharmacokinetic Study

Aim: Ketobemidone is an opioid drug that have been using against pain in various circumstances. The current research was aimed to develop and validate a HPLC-PDA method to estimate the ketobemidone in rat plasma. Materials and Methods: The ketobemidone in the biological matrices (rat plasma) was separated using solvent extraction method using methanol as extracting solvent. An isocratic mobile phase consisting of methanol-water-phosphate buffer at 40:60:0.01 % v/v/v and Kromasil C18 column were used for separation in Liquid Chromatography (LC). Results: The selected linearity range i.e., 0.10-25 mu g/mL was acceptable with r2 value 0.9998 as least square method. The determined Lower Limit of Quantification (LLOQ) is 0.10 mu g/mL. The intermediate precision studies were performed within and between days; and the data obtained are within a significant range, i.e., %RSD <9.2 and the accuracy was within 10.0% of the relative error. Conclusion: The developed method to detect the ketobemidone was successfully validated and it was successfully applied on rat pharmacokinetic study.